Representative before the EPO

Company dna novitas patent ab
no operation time available
1 office
active in Legal Services

Representative before the EPO

Company dna zacco sweden ab
no operation time available
1006.54
1 office
active in Legal Services

Representative before the EPO

Company dna albihns dot zacco ab
no operation time available
1 office
active in Legal Services

We have observed 12 EP applications Lars Höglund has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 16, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11804984

ANTIBODIES AGAINST ROR1 AND USES THEREOF

IPC classification:
A61K 39/02, C07K 16/28
Agent:
Lars Höglund, Zacco Sweden AB
Agent:
Lars Höglund, Novitas Patent AB
Status:
The patent has been granted
EP12711326

TARGETED CYTOKINE FOR TREATMENT OF MUSCULOSKELETAL DISEASES

IPC classification:
A61K 38/18, A61K 39/395, C07K 14/495
Agent:
Zacco Denmark A/S
Agent:
Lars Höglund, Zacco Sweden AB
Status:
The patent has been granted
EP13190948

Device for X-ray examinations

IPC classification:
A61B 6/00, A61B 6/04
Agent:
Lars Höglund, Zacco Sweden AB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12825347

RAPID DETECTION OF METABOLIC ACTIVITY

IPC classification:
G01N 21/65, G01N 33/483
Agent:
Zacco Denmark A/S
Agent:
Lars Höglund, Zacco Sweden AB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12709223

DIAGNOSTIC ASSAY TO PREDICT CARDIOVASCULAR RISK

IPC classification:
G01N 33/68
Applicant:
Emory University
Agent:
Zacco Denmark A/S
Agent:
Lars Höglund, Zacco Sweden AB
Status:
GRANT OF PATENT INTENDED
EP12802262

LIQUID PHARMACEUTICAL COMPOSITION COMPRISING NITISINONE

IPC classification:
A61K 9/10, A61K 31/122, A61P 3/00
Agent:
Johanna Bergh, Awapatent AB
Agent:
Lars Höglund, Zacco Sweden AB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12776215

SYSTEM AND METHOD FOR SECURING TISSUE TO BONE

IPC classification:
A61B 17/04, A61B 17/08
Agent:
Zacco Denmark A/S
Agent:
Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB
Agent:
Lars Höglund, Zacco Sweden AB
Status:
EXAMINATION IN PROGRESS
EP12702124

ENHANCED FERMENTATION OF CELLODEXTRINS AND BETA-D-GLUCOSE

IPC classification:
C07K 14/195, C07K 14/37, C12N 9/00, C12N 9/90, C12P 5/00
Applicant:
University of California
Agent:
Lars Höglund, Zacco Sweden AB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13791248

METHODS AND USES FOR PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) INHIBITORS

IPC classification:
A61K 31/4745, A61K 31/7088, A61K 38/17, A61K 39/395, A61P 29/00
Agent:
Lars Höglund, Novitas Patent AB
Status:
EXAMINATION IN PROGRESS
EP13731869

SALTS OF SAXAGLIPTIN WITH ORGANIC ACIDS

IPC classification:
A61K 31/403, A61P 3/00, C07D 209/52
Agent:
Lars Höglund, Novitas Patent AB
Status:
EXAMINATION IN PROGRESS
EP11846918

PHENOTYPING TUMOR-INFILTRATING LEUKOCYTES

IPC classification:
C12Q 1/68, G01N 33/574
Applicant:
University College Dublin (University College Dublin)
Applicant:
University of California
Agent:
Lars Höglund, Zacco Sweden AB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12744410

CITRATE FREE PHARMACEUTICAL COMPOSITIONS COMPRISING ANAKINRA

IPC classification:
A61K 9/08, A61K 9/10, A61K 38/17, A61K 38/20, A61K 47/02, A61K 47/26, A61P 29/00
Agent:
Awapatent AB
Agent:
Lars Höglund, Zacco Sweden AB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature